Pleural Manometry in Thoracocentesis
Pleural Manometry During Thoracocentesis in Patients With Malignant Pleural Effusion: How Much Fluid Should we Drain?
1 other identifier
interventional
110
1 country
1
Brief Summary
The study aiming to measure the pleural pressure during thoracocentesis in patients with pleural effusion and the value of their measurement in both diagnostic and therapeutic decisions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 15, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedApril 1, 2022
March 1, 2022
2.5 years
April 15, 2020
March 21, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the pleural pressure
To measure the pleural pressure(mmHg) during thoracocentesis in patients with pleural effusion using a simple water pleural manometer
Continous monitoring during the whole session of thoracocentesis
Study Arms (2)
Manometer Group
EXPERIMENTALTherapeutic thoracentesis will be performed in a sitting position. wide bore catheter as a pleural catheter will be inserted into the pleural cavity. simple water manometer will be connected to the pleural catheter via 3-way adapter.connected to the infusion lines with one draining into the drainage collection bottle and the other pre-flushed with normal saline hanging down till 40 cm below the puncture site and then rising up (forming a "U") with the ascending arm taped to the IV stand. baseline pleural pressure will be registered before the beginning of pleural fluid withdrawal. Pleural pressure curve will subsequently be registered after the withdrawal of each 200 ml of pleural fluid up to a total volume of 1000 ml.
Conventional Group
NO INTERVENTIONTherapeutic thoracentesis will be performed in a sitting position. The skin will be cleaned with betadine antiseptic solution. Pleural aspiration should take place in a clean area using full aseptic techniques. 5-10 cc Lidocaine 2% will be given as local anesthetic in the site of puncture. the IV cannula is advanced till fluid is aspirated. Then, the needle is withdrawn and the catheter is fixed to two 3-way adapters fixed in series placed in between. connected to the infusion lines with one draining into the drainage collection bottle.
Interventions
Recording pleural pressure during therapeutic thoracocentesis using a simple water manometer.
Eligibility Criteria
You may qualify if:
- age between 18 and 85 years,
- pleural effusion occupying at least one-third of the ipsilateral hemithorax in P-A chest radiograph (CXR)
- no contraindications for therapeutic thoracentesis
- general health condition allowing prolonged procedure of therapeutic thoracentesis.
You may not qualify if:
- patients with very small amounts of pleural effusion
- patients on mechanical ventilation
- patients using anticoagulant therapy
- patients refusing to be subjected to thoracocentesis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiothoracic Surgery Hospital, Faculty of Medicine, Ain Shams University
Cairo, Egypt
Related Publications (1)
Hassaballa AS, Mostafa A, Hikal T, Elnori A, Elsayed HH. Pleural manometry during thoracocentesis in patients with malignant pleural effusion: A randomized controlled trial. Can J Respir Ther. 2023 Jan 20;59:33-44. doi: 10.29390/cjrt-2022-047. eCollection 2023.
PMID: 36741303DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
April 15, 2020
First Posted
June 9, 2020
Study Start
July 1, 2019
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
April 1, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share